A comparison of dynamic characteristics of fluconazole, itraconazole, and amphotericin B against Cryptococcus neoformans using time-kill methodology
- 1 October 2000
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 38 (2) , 87-93
- https://doi.org/10.1016/s0732-8893(00)00173-5
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Pharmacodynamics of fluconazole, itraconazole, and amphotericin B against Candida albicans☆Diagnostic Microbiology and Infectious Disease, 2000
- Pharmacodynamics of Fluconazole in a Murine Model of Systemic CandidiasisAntimicrobial Agents and Chemotherapy, 1998
- Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicansAntimicrobial Agents and Chemotherapy, 1997
- Treatment of fungal infection in AIDSJournal of Antimicrobial Chemotherapy, 1996
- Comparison of the Efficacy of Amphotericin B and Fluconazole in the Treatment of Cryptococcosis in Human Immunodeficiency Virus-Negative Patients: Retrospective Analysis of 83 CasesClinical Infectious Diseases, 1996
- Amphotericin B as Primary Therapy for Cryptococcosis in Patients with AIDS: Reliability of Relatively High Doses Administered over a Relatively Short PeriodClinical Infectious Diseases, 1995
- Cryptococcal Meningitis and AIDSClinical Infectious Diseases, 1993
- Pharmacodynamics of intravenous ciprofloxacin in seriously ill patientsAntimicrobial Agents and Chemotherapy, 1993
- Role of pharmacokinetics in the outcome of infectionsAntimicrobial Agents and Chemotherapy, 1988
- Clinical Response to Aminoglycoside Therapy: Importance of the Ratio of Peak Concentration to Minimal Inhibitory ConcentrationThe Journal of Infectious Diseases, 1987